Michael Staab

BioPark Regensburg GmbH is a company located in Regensburg, DE that focuses on biotechnology, medical technology, diagnostics & analysis, and health economy. BioPark Regensburg is ultimately controlled by the City of Regensburg (Germany). The company provides a perfect framework for start-ups, companies, and institutes in the country triangle of Germany, Austria, and the Czech Republic. The company is considered a pioneer in many areas, and it has developed innovative therapy methods and chemically optical microsensors. The company was founded in 1999, and Thomas Diefenthal has been the CEO of the company since then.